National Notifiable Diseases Surveillance System (NNDSS)
OMB Control Number 0920-0728
Expiration Date: 01/31/2019
Program Contact
Kim Gadsden-Knowles
Deputy Associate Director for Surveillance
Division of Health Informatics and Surveillance
Center for Surveillance, Epidemiology and Laboratory Services
Centers for Disease Control and Prevention
1600 Clifton Rd, MS-E97
Atlanta, GA 30329
Phone: (404) 498-0355
E-mail: klg6@cdc.gov
Submission Date: December 13, 2016
Circumstances of Change Request for OMB 0920-0728
This is a nonmaterial/non-substantive change request for OMB No. 0920-0728, expiration date 01/31/2019, for the reporting of Nationally Notifiable Diseases. The National Notifiable Diseases Surveillance System (NNDSS) is the nation’s public health surveillance system that enables all levels of public health (local, state, territorial, federal and international) to monitor the occurrence and spread of the diseases and conditions that the Council of State and Territorial Epidemiologists (CSTE) has officially designated as either “nationally notifiable” or as under “national surveillance.” The NNDSS facilitates the submission and aggregation of case notification data voluntarily submitted to CDC from 57 jurisdictions: health departments in every U.S. state, New York City, Washington DC, and 5 U.S. territories (American Samoa, the Commonwealth of Northern Mariana Islands, Guam, Puerto Rico, and the U.S. Virgin Islands). NNDSS also facilitates relevant data management, analysis, interpretation and dissemination of the information. The data are used to monitor health occurrence of notifiable conditions and to plan and conduct prevention and control programs at the state, territorial, local and national levels.
This request is for the addition of 4 new disease-specific data elements for Cyclosporiasis.
Two of the new data elements pertain to domestic travel history during the relevant exposure period. Previously approved travel variables focused solely on international travel; outbreak investigations typically focus on the subset of cases that were acquired in the United States. By collecting domestic travel data elements (in addition to information about international travel), we can determine where within the United States the exposure did or likely occurred and more quickly begin an outbreak investigation, if indicated. Additionally, we would like to collect information on medication(s) administered to help ensure appropriate treatment was given. Lastly, we would like to collect information on the performing laboratory type, so that we can focus public health outreach and training activities to the labs most often performing Cyclosporiasis testing.
The new data elements requiring the change request are in the following table:
New Cyclosporiasis Data Elements
Data Element Identifier |
Data Element Name |
Data Element Description |
TBD |
Travel |
In the two weeks before onset of illness, did the case-patient travel out of their state or US? |
TBD |
Travel State |
Domestic destination or state(s) the case-patient traveled to in the two weeks before onset of illness |
TBD |
Medication Administered |
What treatment did the case-patient receive? |
TBD |
Performing Laboratory Type |
Performing laboratory type |
Burden
The annualized burden hours and cost to reporting jurisdictions to submit these data to CDC does not change from the original estimates in the “Estimates of Annualized Burden Hours and Costs” section in A.12 of OMB No. 0920-0728 because reporting jurisdictions already collect this information and fewer than 1,000 cases of cyclosporiasis are reported each year in the United States (average of approximately 400 cases over the past five years). There will be no increase in burden for the reporting jurisdictions to send those data elements to CDC since most case notifications are submitted from already existing databases.
A.12A. Estimates of Annualized Burden Hours
Type of Respondents |
Form Name |
Number of Respondents |
Number of Responses per Respondent |
Average Burden Per Response (in hours) |
Total Burden (in hours) |
States |
Weekly and Annual |
50 |
52 |
10 |
26,000 |
Territories |
Weekly and Annual |
5 |
52 |
5 |
1,300 |
Cities |
Weekly and Annual |
2 |
52 |
10 |
1,040 |
Total |
|
|
|
|
28,340 |
A.12B. Estimates of Annualized Cost Burden
Type of Respondents |
Form Name |
Number of Respondents |
Number of Responses per Respondent |
Average Burden Per Response (in hours) |
Total Burden Hours |
Hourly Wage Rate |
Respondent Cost |
States |
Weekly and Annual |
50 |
52 |
10 |
26,000 |
$35.63 |
$926,380 |
Territories |
Weekly and Annual |
5 |
52 |
5 |
1,300 |
$35.63 |
$46,319 |
Cities |
Weekly and Annual |
2 |
52 |
2 |
1,040 |
$35.63 |
$37,055 |
Total |
|
|
|
|
|
|
$1,009,754 |
File Type | application/msword |
Author | Jones, Jeffrey L. (CDC/CGH/DPDM) |
Last Modified By | Gadsden-Knowles, Kim (CDC/OPHSS/CSELS) |
File Modified | 2016-12-13 |
File Created | 2016-12-13 |